Evidence map›Paper›PMID 21128318›Full record

ArticleWorld journal of gastroenterology2010

Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution.

Mohamed Amine Zaouali, Susagna Padrissa-Altés, Ismail Ben Mosbah, Hassen Ben Abdennebi, Olivier Boillot, Antoni Rimola, Dalila Saidane-Mosbahi, Joan Roselló-Catafau

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Emerging concepts in liver graft preservation.World journal of gastroenterology · 2015
    Review
  11. Article
  12. Article
  13. How to protect liver graft with nitric oxide.World journal of gastroenterology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mohamed Amine ZaoualiExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas, 08036 Barcelona, Spain. jrcbam@iibb.csic.es
Susagna Padrissa-Altés
Ismail Ben Mosbah
Hassen Ben Abdennebi
Olivier Boillot
Antoni Rimola
Dalila Saidane-Mosbahi
Joan Roselló-Catafau
Institut d'Investigacions Biomèdiques de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the benefits of insulin like growth factor-1 (IGF-1) supplementation to serum-free institut georges lopez-1 (IGL-1) solution to protect fatty liver against cold ischemia reperfusion injury.

methodsSteatotic livers were preserved for 24 h in IGL-1 solution supplemented with or without IGF-1 and then perfused "ex vivo" for 2 h at 37degrees C. We examined the effects of IGF-1 on hepatic damage and function (transaminases, percentage of sulfobromophthalein clearance in bile and vascular resistance). We also studied other factors associated with the poor tolerance of fatty livers to cold ischemia reperfusion injury such as mitochondrial damage, oxidative stress, nitric oxide, tumor necrosis factor-α (TNF-α) and mitogen-activated protein kinases.

resultsSteatotic livers preserved in IGL-1 solution supplemented with IGF-1 showed lower transaminase levels, increased bile clearance and a reduction in vascular resistance when compared to those preserved in IGL-1 solution alone. These benefits are mediated by activation of AKT and constitutive endothelial nitric oxide synthase (eNOS), as well as the inhibition of inflammatory cytokines such as TNF-α. Mitochondrial damage and oxidative stress were also prevented.

conclusionIGL-1 enrichment with IGF-1 increased fatty liver graft preservation through AKT and eNOS activation, and prevented TNF-α release during normothermic reperfusion.

Indexed as

Cold IschemiaAlanine TransaminaseAnimalsAspartate AminotransferasesBileExtracellular Signal-Regulated MAP KinasesFatty LiverInsulin-Like Growth Factor ILiverMitochondria, LiverNitric OxideNitric Oxide Synthase Type IIIOrgan Preservation SolutionsOxidative Stressp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktAlanine TransaminaseAspartate AminotransferasesExtracellular Signal-Regulated MAP KinasesIGL-1 solutionInsulin-Like Growth Factor INitric OxideNitric Oxide Synthase Type IIINos3 protein, ratOrgan Preservation Solutionsp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktTumor Necrosis Factor-alpha

Identifiers

PMID21128318
PMCPMC2997984
OpenAlexW1975996964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.